Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5497 record(s)

Req # A-2023-001201

Adverse Drug Reactions (ADRs). Report numbers: E2B_06645501, E2B_06645517, E2B_06657795, E2B_06666075, E2B_06679045, E2B_06679059, E2B_06679204, E2B_06680655, E2B_06690731.

Organization: Health Canada

157 page(s)
March 2024

Req # A-2023-001202

Adverse Drug Reactions (ADRs) for Abilify Maintena, Aripiprazole. Report numbers: 001065912, 001069455, E2B_06655775, E2B_06662846. ADRs for Sucroferric oxyhydroxide. Report numbers: E2B_06595703, E2B_06620171, E2B_06620172, E2B_06657227, E2B_06689472, E2B_06696864.

Organization: Health Canada

106 page(s)
March 2024

Req # A-2023-001211

Adverse Drug Reactions (ADRs) for Lansoprazole. Report numbers: E2B_06701592, E2B_06688522, E2B_06690949, E2B_06686903, 001068701, 001064552.

Organization: Health Canada

372 page(s)
March 2024

Req # A-2023-001218

Adverse Drug Reactions (ADRs). Report numbers: 001056376, E2B_06602443, E2B_06597136, E2B_06636224, E2B_06624489, E2B_06665895, 001008281.

Organization: Health Canada

345 page(s)
March 2024

Req # A-2023-001224

Adverse Drug Reaction (ADR). Report number: E2B_06648009.

Organization: Health Canada

46 page(s)
March 2024

Req # A-2023-001228

Adverse Drug Reactions (ADRs). Report numbers: 001029011, 001032323.

Organization: Health Canada

967 page(s)
March 2024

Req # A-2023-001248

Adverse Drug Reactions (ADRs). Report numbers: 001066645, E2B_06652773, E2B_06652035, E2B_06667006, E2B_06658740, E2B_06696430.

Organization: Health Canada

516 page(s)
March 2024

Req # A-2023-001251

Adverse Drug Reactions (ADRs). Report numbers: E2B_06237597, E2B_06249123, E2B_01569944, 1033939, E2B_06276132, E2B_06276260, E2B_06320663, E2B_06320721, 1037986, E2B_06332106.

Organization: Health Canada

101 page(s)
March 2024

Req # A-2023-001252

Adverse Drug Reactions (ADRs). Report numbers: E2B_06372261, E2B_06377856, 1050131, 1049743, E2B_06339982, 1042341, 1048640, 1038544, E2B_06399744, E2B_06428505.

Organization: Health Canada

83 page(s)
March 2024

Req # A-2023-001255

Adverse Drug Reactions (ADRs). Report numbers: E2B_06659829, E2B_06626329.

Organization: Health Canada

38 page(s)
March 2024
Date modified: